Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine versus lidocaine for mandibular impacted tooth extraction
ChiCTR2200059981Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- May 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine and lidocaine in impacted tooth (2 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoints: Onset time of anesthesia, Success rate of anesthesia and 2 more. Planned start May 2022; status: not yet recruiting.
02
Drugs
ropivacainelidocaine
03
Conditions
impacted tooth
Beyond the preview
Go deeper on ChiCTR2200059981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059981.